or Try an Advanced Search...

    Anti Diabetic Drugs Stocks List

    Symbol Grade Name % Change
    NVO D Novo Nordisk A/S -2.14
    TERN F Terns Pharmaceuticals, Inc. 2.32
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Obesity Peptide Hormones Bile Acid Chronic Liver Diseases Diabetes Diabetes Care Endocrine System Glucagon Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hepatitis Hormone Therapy Hormones Inflammation Insulin Life Sciences Liver

    Related ETFs - A few ETFs which own one or more of the above listed Anti Diabetic Drugs stocks.

    Symbol Grade Name Weight
    OZEM F Roundhill GLP-1 & Weight Loss ETF 19.01
    THNR F Amplify Weight Loss Drug & Treatment ETF 13.3
    PPH D Market Vectors Pharmaceutical ETF 7.69
    BELT B BlackRock Long-Term U.S. Equity ETF 5.28
    AADR A WCM BNY Mellon Focused Growth ADR ETF 4.85
    View all Anti Diabetic Drugs ETFs...
    Compare ETFs
    Compare OZEM to PPH Compare PPH to AADR Compare THNR to AADR

        Anti Diabetic Drugs Stocks Recent News

        Date Stock Title
        Nov 21 NVO Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
        Nov 21 NVO Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
        Nov 20 NVO More companies covering weight loss drugs for their employees
        Nov 20 NVO Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
        Nov 20 NVO Is Novo Nordisk Stock a Buy Right Now?
        Nov 20 NVO RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
        Nov 19 NVO Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
        Nov 19 NVO Sector Update: Health Care Stocks Decline
        Nov 19 NVO Novo Nordisk Unusual Options Activity For November 19
        Nov 19 NVO Sector Update: Health Care Stocks Mixed Tuesday Afternoon
        Nov 19 TERN Top 3 Health Care Stocks You'll Regret Missing In Q4
        Nov 19 NVO Novo Erases 2024 Gain, Wiping Out $210 Billion in Value
        Nov 19 NVO Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
        Nov 19 NVO Employers Get Pressure to Pay for Drugs Like Wegovy
        Nov 18 NVO RFK Jr.'s HHS nomination sparks concern over pharma stocks
        Nov 18 TERN Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
        Nov 18 NVO Novo Nordisk reportedly launches Wegovy in China
        Nov 18 NVO How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
        Nov 18 NVO Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
        Nov 18 NVO Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Obesity Peptide Hormones Bile Acid Chronic Liver Diseases Diabetes Diabetes Care Endocrine System Glucagon Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hepatitis Hormone Therapy Hormones Inflammation Insulin Life Sciences Liver
        Anti Diabetic Drugs

        Anti-diabetic drugs are medications used to treat people with diabetes mellitus. They work by either increasing the amount of insulin produced by the body, or by helping the body use the insulin it produces more effectively. Common types of anti-diabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors.

        Browse All Tags